Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Antares Pharma Inc

+ Add to Watchlist


2.2700 USD 0.00000.00%

As of 09:40:57 ET on 01/29/2015.

Snapshot for Antares Pharma Inc (ATRS)

Open: 2.2600 Day's Range: 2.2500 - 2.2700 Volume: 60,886
Previous Close: 2.2700 52wk Range: 1.8200 - 4.9600 1-Yr Rtn: -48.76%

Stock Chart for ATRS

No chart data available.
  • ATRS:US 2.2700
  • 1D
  • 1M
  • 1Y
Interactive ATRS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATRS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2301
Est. EPS (USD) (12/2014) -0.2350
Est. PEG Ratio -
Market Cap (M USD) 298.92
Shares Outstanding (M) 131.68
30 Day Average Volume 1,037,856
Price/Book (mrq) 5.8741
Price/Sale (ttm) 12.7744
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATRS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ATRS

Antares Pharma, Inc. develops pharmaceutical delivery systems, including needle-free and mini-needle injector systems and transdermal gel technologies. The Company distributes its needle-free injector systems in various countries. Antares also conducts research and development with transdermal gel products and has several products in clinical evaluation with partners.

Eamonn P HobbsPresident/CEORobert F Apple "Bob"Exec VP/COO
James E FickenscherSenior VP/CFOJennifer Evans StaceySenior VP/Secy/Gen Counsel:HR
More Company Profile & Key Executives for ATRS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • ATRS News

  • Industry News

Sponsored Links
sec ||= nil